🔗 Permalink

Inventor profile of:

Jacobus C.A. van MEEL

City:

Moedling

Country:

Austria

Published Applications:

Last publication date:

2018-12-20

Top Assignees for applications by Jacobus C.A. van MEEL

The entities that hold a legal rights for patent applications filed by inventor van MEEL Jacobus C.A.:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH 9 Ingelheim am Rhein, Germany
Boehringer Ingelheim Pharma GmbH Co. KG 4 Ingelheim, Germany
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2 Ingelheim, Germany
Boehringer Ingelheim Pharma KG 1 Ingelheim, Germany
BOEHRINGER INGELHEIM PHARMA GMBH &CO. KG 1 Ingelheim am Rhein, Germany

Recent patent applications by van MEEL Jacobus C.A.

Jacobus C.A. van MEEL from Moedling, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-12-20

US20180360834A1

Human necessities

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

#2 | 2018-03-29

US20180086744A1

Chemistry; metallurgy

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

#3 | 2017-04-27

US20170112835A1

Human necessities

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES

#4 | 2015-10-01

US20150272954A1

Human necessities

Quinazoline derivatives for the treatment of cancer diseases

#5 | 2015-09-24

US20150265610A1

Human necessities

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#6 | 2014-07-17

US20140199298A1

Chemistry; metallurgy

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

#7 | 2014-02-27

US20140057898A1

Human necessities

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#8 | 2013-07-11

US20130178487A1

Human necessities

Quinazoline derivatives for the treatment of cancer diseases

#9 | 2011-07-14

US20110171289A1

Human necessities

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#10 | 2011-06-09

US20110136826A1

Human necessities

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#11 | 2011-02-17

US20110039863A1

Human necessities

COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS

#12 | 2009-12-10

US20090306101A1

Chemistry; metallurgy

COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS

#13 | 2009-12-10

US20090306044A1

Human necessities

Quinazoline derivatives for the treatment of cancer diseases

#14 | 2009-08-06

US20090197876A1

Chemistry; metallurgy

Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments

#15 | 2008-10-16

US20080254040A1

Human necessities

Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis

#16 | 2007-01-04

US20070004757A1

Chemistry; metallurgy

Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments

#17 | 2006-08-31

US20060194813A1

Chemistry; metallurgy

Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions

#18 | 2005-02-24

US20050043389A1

Chemistry; metallurgy

Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments

#19 | 2005-02-24

US20050043233A1

Human necessities

Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis

#20 | 2005-02-15

US10666643

Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs

InventorID:

335956 ⎘